Industry: New medical infrastructure is in full swing, and 2023 will still be the peak of medical device procurement

【Pharmaceutical Network Market Analysis】Since 2020, the shortcomings of insufficient domestic medical resources and incomplete construction have been exposed, and relevant departments have successively issued a series of policies, and the suppression of the number of new hospital projects has been significantly restored, bringing new increments
to the medical device market.
At present, the construction of new medical infrastructure is still in full swing
.
Caixin Securities believes that this round of medical infrastructure has gradually rolled out across the country since the epidemic, and with the construction of new hospital campuses, the large-scale production capacity of this round of new medical infrastructure will be released one after another, and related enterprises such as medical special projects, medical equipment, and medical informatization will also benefit
one after another.
The agency also said that new medical infrastructure continues to be booming, and it is expected that 2023 will still be the peak
of procurement.
According to the statistics of Orient Securities, the number of completed projects from 2021 to 2023 accounted for 26.
6%, 34.
2% and 20.
9% respectively
.
Therefore, some institutions pointed out that from the perspective of time calculation, 2022-2023 may be the peak
of the completion of this new infrastructure project.
In September 2022, the National Health Commission issued a notice on the use of financial discount loans to purchase medical equipment, which covers six major purchase entities and specific equipment equipment lists
.
According to the list of loan projects that have been reported and approved so far, the industry expects that the demand for medical equipment loans will be about 200 billion yuan nationwide, which will be enough to make up for the lack of cash flow caused by the pressure on the hospital's diagnosis and treatment volume, and there is a certain net increment
.
The first quarter of 2023 is expected to bring net incremental orders
to related medical device companies.
With the release of the medical equipment discount loan policy, many domestic medical equipment companies have also attracted the attention
of investors since September 2022.
Among them, Mindray Medical, a leading domestic medical device company, said on the interactive platform on January 4 that it expects the loan demand related to Mindray medical products to reach 20 billion yuan
.
According to the list of existing projects, the subsidized interest loan policy has the most significant pulling effect on the medical imaging production line, and the pulling effect on the life information and support production line is slightly smaller than that of the medical imaging production line, and the short-term pulling effect on the in vitro diagnostic production line is the smallest
.
Xiangyu Medical, a rehabilitation medical device company, replied to investors at the end of 2022 that the financial discount loan to update and transform medical equipment will release the procurement demand
of medical institutions for medical equipment.
As one of the equipment encouraged by subsidized interest loans, rehabilitation equipment is a very important opportunity
for the entire rehabilitation industry.
In December 2022, Baolaite said in an institutional survey that from the perspective of the industry, the recent medical equipment discount loan policy is expected to effectively solve the problem of financial constraints in equipment purchase by medical institutions, release certain medical equipment procurement needs, and form a good
for medical equipment manufacturers 。 From the company's point of view, the company, as a national brand that has been deeply engaged in the medical device industry for many years, has a rich product category and mature product structure in the field of health monitoring and blood purification, and the company's independent research and development and manufacturing of monitors, hemodialysis equipment, dialysis water treatment equipment and other medical equipment have excellent product competitiveness
.
Overall, this policy is expected to have a positive impact
on the company's main business.
Overall, at present, China's medical device market is developing rapidly, and favorable policies will further increase the development of
the industry.
According to data, the scale of China's medical device industry will exceed 300 billion
for the first time in 2015.
It is estimated that by 2025, the size of China's medical device market will reach 1,716.
8 billion yuan
.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.